1990PubMedRequires access

[Prenatal diagnosis of genetic diseases].

Yu Seob Shin

Open publisher page 0 citations

Abstract

Many severe genetic disorders can be identified in utero to offer parents the option to terminating the pregnancy und preventing the birth of an affected child. Various techniques of gaining tissues or cells for prenatal testings are available such as fetal blood or liver sampling, amniocentesis and chorionic villous sampling (CVS). The first step of the diagnosis is at the cell function level which involves the identification of accumulated or missing metabolites in amniotic fluid by chemical methods. The second step is to study the protein function, biochemical analysis of blood cells, cultured amniocytes and direct or cultured chorionic villi. The third step is the molecular genetic, the deoxyribonucleic acid (DNA) analysis in fetal cells or tissues. The recently developed first-trimester CVS procedure represents a rapid and safe diagnosis in utero.

About this research paper

What this paper is about

Many severe genetic disorders can be identified in utero to offer parents the option to terminating the pregnancy und preventing the birth of an affected child. Various techniques of gaining tissues or cells for prenatal testings are available such as fetal blood or liver sampling, amniocentesis and chorionic villous sampling (CVS). The first step of the diagnosis is at the cell function level which involves the identification of accumulated or missing metabolites in amniotic fluid by chemical methods. The second step is to study the protein function, biochemical analysis of blood cells, cultured amniocytes and direct or cultured chorionic villi. The third step is the molecular genetic, the deoxyribonucleic acid (DNA) analysis in fetal cells or tissues. The recently developed first-trimester CVS procedure represents a rapid and safe diagnosis in utero.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Many severe genetic disorders can be identified in utero to offer parents the option to terminating the pregnancy und preventing the birth of an affected child. Various techniques of gaining tissues or cells for prenatal testings are available such as fetal blood or liver sampling, amniocentesis and chorionic villous sampling (CVS). The first step of the diagnosis is at the cell function level which involves the identification of accumulated or missing metabolites in amniotic fluid by chemical methods. The second step is to study the protein function, biochemical analysis of blood cells, cultured amniocytes and direct or cultured chorionic villi. The third step is the molecular genetic, the deoxyribonucleic acid (DNA) analysis in fetal cells or tissues. The recently developed first-trimester CVS procedure represents a rapid and safe diagnosis in utero.

Key concepts: Amniocentesis, Chorionic villus sampling, Prenatal diagnosis, In utero, Chorionic villi, Fetus, Amniotic fluid, Cell-free fetal DNA

Related papers

Back to paper searchBrowse research topicsOriginal source
[Prenatal diagnosis of genetic diseases]. — Research Paper | ScholarLens